Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Therapies and procedures
Advance the treatment and lifetime management of patients with symptomatic severe aortic stenosis using the innovative Evolut™ TAVR platform.
Since 2014 we have been building on the trusted and proven CoreValve™ platform. Explore the purposeful innovation of our Evolut TAVR systems.
Learn more about the prevalence and etiology of symptomatic, severe aortic stenosis (SSAS), detection and diagnosis, patient selection criteria, and available treatment options.
Find resources designed to help you educate patients — from learning about aortic stenosis to understanding the TAVR procedure.
Review clinical studies that demonstrate the efficacy of the Evolut TAVR platform, its procedural outcomes, and real-world results.
Get insights on the Evolut platform from heart valve experts as they discuss procedural technique, implant strategies, and contemporary data.
TAVR risks may include, but are not limited to, death, stroke, damage to the arteries, bleeding, and need for permanent pacemaker.